학술논문
921P HB-200 arenavirus-based immunotherapy plus pembrolizumab as a first-line treatment of patients with recurrent/metastatic HPV16 positive head and neck cancer
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S581-S582
Subject
Language
ISSN
0923-7534